# Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment

> **NCT07500324** · NA · RECRUITING · sponsor: **Fondazione G.B. Bietti, IRCCS** · enrollment: 260 (estimated)

## Conditions studied

- Age-Related Macular Degeneration (AMD)
- Diabetic Retinopathy (DR)
- Retinal Detachment

## Interventions

- **DEVICE:** Biological Sample Collection

## Key facts

- **NCT ID:** NCT07500324
- **Lead sponsor:** Fondazione G.B. Bietti, IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07500324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07500324, "Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07500324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*